Show items per page
Elements: 1
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? Finckh, Axel; Ciurea, A.; Brulhart, L.; Moller, B.; ... Gabay, Cem 2010